- Home
- LFT vs PAVM Comparison
LFT vs PAVM Comparison
Compare LFT & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFT | PAVM |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | 41 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.6M | 43.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LFT | PAVM |
|---|---|---|
| Price | $0.69 | $4.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 266.6K | 8.6K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | ★ 18.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $668.15 | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | $13.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $0.21 |
| 52 Week High | $2.37 | $28.44 |
Technical Indicators
Market Signals| Indicator | LFT | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 28.99 | 42.21 |
| Support Level | N/A | $4.45 |
| Resistance Level | $1.40 | $6.56 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 17.75 | 26.39 |
Price Performance
Historical ComparisonAbout LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.